Daskalakis, M.; Feller, A.; Noetzli, J.; Bonadies, N.; Arndt, V.; Baerlocher, G.M.; The NICER Working Group.
Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers 2021, 13, 6269.
https://doi.org/10.3390/cancers13246269
AMA Style
Daskalakis M, Feller A, Noetzli J, Bonadies N, Arndt V, Baerlocher GM, The NICER Working Group.
Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers. 2021; 13(24):6269.
https://doi.org/10.3390/cancers13246269
Chicago/Turabian Style
Daskalakis, Michael, Anita Feller, Jasmine Noetzli, Nicolas Bonadies, Volker Arndt, Gabriela Maria Baerlocher, and The NICER Working Group.
2021. "Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017" Cancers 13, no. 24: 6269.
https://doi.org/10.3390/cancers13246269
APA Style
Daskalakis, M., Feller, A., Noetzli, J., Bonadies, N., Arndt, V., Baerlocher, G. M., & The NICER Working Group.
(2021). Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers, 13(24), 6269.
https://doi.org/10.3390/cancers13246269